Nifty
:
22147.00
Sensex
:
73088.33
151.15 (0.69%)
599.34 (0.83%)
Nifty
Sensex
:
:
22147.00
73088.33
151.15 (0.69%)
599.34 (0.83%)

Bafna Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :
50/99

BSE: 532989 | NSE: BAFNAPH

NSE BSE
86.80
19-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  85.15
  •  86.95
  •  85.10
  •  87.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1478
  •  1.26
  •  124.45
  •  75.90

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 200.49
  • 17.80
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 209.21
  • N/A
  • 2.52

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 88.43%
  • 3.09%
  • 7.66%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 0.82%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.22
  • 21.46
  • 17.44

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.95
  • -
  • 8.82

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.81
  • -
  • 24.83

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 37.51
  • 44.81

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.93
  • 3.93
  • 4.11

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.36
  • 18.01
  • 19.90

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
-
42.47
43.63
47.17
64.96
85.32
138.79
185.34
175.77
128.63
Net Sales Growth
-
-2.66%
-7.50%
-27.39%
-23.86%
-38.53%
-25.12%
5.44%
36.65%
 
Cost Of Goods Sold
-
16.17
23.94
33.34
49.52
63.00
77.80
124.51
122.43
85.98
Gross Profit
-
26.30
19.69
13.83
15.45
22.32
60.99
60.83
53.34
42.65
GP Margin
-
61.93%
45.13%
29.32%
23.78%
26.16%
43.94%
32.82%
30.35%
33.16%
Total Expenditure
-
41.25
56.70
82.30
70.77
84.80
115.33
162.50
153.29
109.99
Power & Fuel Cost
-
2.69
2.50
2.13
2.05
2.54
2.01
2.08
2.03
1.73
% Of Sales
-
6.33%
5.73%
4.52%
3.16%
2.98%
1.45%
1.12%
1.15%
1.34%
Employee Cost
-
10.25
9.01
7.47
6.81
6.94
10.74
13.98
10.88
5.83
% Of Sales
-
24.13%
20.65%
15.84%
10.48%
8.13%
7.74%
7.54%
6.19%
4.53%
Manufacturing Exp.
-
8.09
8.08
8.36
6.06
8.19
13.02
11.08
9.73
11.43
% Of Sales
-
19.05%
18.52%
17.72%
9.33%
9.60%
9.38%
5.98%
5.54%
8.89%
General & Admin Exp.
-
3.52
2.60
2.03
2.21
2.30
4.68
5.58
5.53
3.38
% Of Sales
-
8.29%
5.96%
4.30%
3.40%
2.70%
3.37%
3.01%
3.15%
2.63%
Selling & Distn. Exp.
-
0.40
0.81
2.15
1.23
0.44
3.38
2.98
2.36
1.12
% Of Sales
-
0.94%
1.86%
4.56%
1.89%
0.52%
2.44%
1.61%
1.34%
0.87%
Miscellaneous Exp.
-
0.12
9.77
26.82
2.90
1.39
3.70
2.29
0.33
0.51
% Of Sales
-
0.28%
22.39%
56.86%
4.46%
1.63%
2.67%
1.24%
0.19%
0.40%
EBITDA
-
1.22
-13.07
-35.13
-5.81
0.52
23.46
22.84
22.48
18.64
EBITDA Margin
-
2.87%
-29.96%
-74.48%
-8.94%
0.61%
16.90%
12.32%
12.79%
14.49%
Other Income
-
0.26
0.39
31.33
1.14
1.98
4.90
1.85
3.04
1.48
Interest
-
0.10
2.13
6.94
11.47
12.96
13.46
13.21
11.91
8.32
Depreciation
-
3.27
3.48
3.97
4.22
4.86
5.99
8.99
8.25
6.30
PBT
-
-1.88
-18.29
-14.72
-20.36
-15.32
8.90
2.49
5.36
5.50
Tax
-
0.00
1.07
2.19
-0.90
-0.18
-0.15
1.05
1.48
3.47
Tax Rate
-
0.00%
-5.85%
-14.88%
4.42%
1.17%
-2.47%
42.17%
26.96%
64.62%
PAT
-
-2.17
-19.88
-16.74
-19.09
-14.03
6.18
1.40
3.96
1.85
PAT before Minority Interest
-
-1.88
-19.36
-16.91
-19.46
-15.14
6.22
1.44
4.01
1.91
Minority Interest
-
-0.29
-0.52
0.17
0.37
1.11
-0.04
-0.04
-0.05
-0.06
PAT Margin
-
-5.11%
-45.56%
-35.49%
-29.39%
-16.44%
4.45%
0.76%
2.25%
1.44%
PAT Growth
-
-
-
-
-
-
341.43%
-64.65%
114.05%
 
EPS
-
-0.92
-8.39
-7.06
-8.05
-5.92
2.61
0.59
1.67
0.78

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
51.11
19.06
37.93
42.67
57.75
71.78
68.86
67.45
63.82
Share Capital
2.37
23.66
23.66
18.66
18.66
18.66
18.66
18.66
18.38
Total Reserves
-6.61
-4.60
14.27
20.01
39.10
53.12
50.20
45.67
39.57
Non-Current Liabilities
3.02
29.80
41.31
54.72
39.91
16.03
30.65
32.27
32.55
Secured Loans
0.00
20.86
21.08
36.77
35.17
11.64
22.95
25.20
26.33
Unsecured Loans
3.02
2.13
2.17
2.24
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
17.10
70.82
59.85
81.47
95.05
111.09
135.43
160.01
121.77
Trade Payables
12.54
39.56
28.61
23.90
37.70
42.25
41.82
78.70
58.35
Other Current Liabilities
4.56
8.02
7.95
14.19
10.04
11.83
8.33
4.12
4.31
Short Term Borrowings
0.00
23.24
23.29
43.37
45.31
57.01
85.27
74.99
59.11
Short Term Provisions
0.00
0.00
0.00
0.00
2.00
0.00
0.00
2.20
0.00
Total Liabilities
71.31
119.47
138.36
178.31
192.53
199.83
235.83
260.58
218.94
Net Block
35.00
37.05
44.90
48.61
52.61
54.56
69.28
72.99
76.24
Gross Block
74.13
72.91
79.77
79.65
79.67
77.36
92.25
90.50
88.37
Accumulated Depreciation
39.12
35.85
34.88
31.04
27.06
22.80
22.97
17.51
12.13
Non Current Assets
35.22
71.00
89.62
101.12
69.51
72.74
71.88
74.50
77.20
Capital Work in Progress
0.21
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
16.90
16.90
16.90
0.00
0.00
0.00
Long Term Loans & Adv.
0.00
32.95
44.20
35.03
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
1.00
0.53
0.58
0.00
1.28
2.60
1.51
0.96
Current Assets
36.10
48.47
48.74
77.18
122.30
127.09
156.48
178.55
136.62
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
11.41
9.28
10.67
16.74
16.38
16.12
27.40
22.21
23.92
Sundry Debtors
6.03
24.83
24.28
53.78
67.96
88.69
97.51
91.63
83.84
Cash & Bank
8.48
2.71
2.95
2.66
2.71
2.77
2.81
21.07
2.46
Other Current Assets
10.17
6.24
4.51
2.96
35.25
19.51
28.75
43.65
26.39
Short Term Loans & Adv.
2.75
5.40
6.32
1.05
33.58
18.12
24.36
39.92
23.16
Net Current Assets
19.00
-22.35
-11.11
-4.29
27.26
16.00
21.05
18.54
14.85
Total Assets
71.32
119.47
138.36
178.30
192.53
199.83
235.83
260.58
218.94

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
-34.31
-1.79
-7.05
-0.95
0.91
10.66
1.61
36.63
29.25
PBT
-1.88
-18.29
-14.72
-20.36
-15.32
6.21
2.49
5.49
5.37
Adjustment
-19.45
5.45
-19.53
15.50
15.84
-26.56
20.35
17.13
10.17
Changes in Working Capital
-12.97
11.06
27.20
3.91
0.39
33.27
-20.77
14.91
14.75
Cash after chg. in Working capital
-34.31
-1.79
-7.05
-0.95
0.91
12.92
2.08
37.53
30.30
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
0.00
0.00
-2.26
-0.47
-0.90
-1.05
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
32.77
15.36
37.97
-5.42
-0.36
60.13
-6.71
-6.10
-38.01
Net Fixed Assets
-1.43
-0.33
-0.13
0.03
-2.30
14.96
-1.75
-1.71
Net Investments
1.43
0.00
16.90
0.00
0.00
-16.90
0.00
0.00
Others
32.77
15.69
21.20
-5.45
1.94
62.07
-4.96
-4.39
Cash from Financing Activity
7.30
-13.81
-30.63
6.31
-0.61
-70.83
-13.16
-11.93
-0.69
Net Cash Inflow / Outflow
5.77
-0.24
0.29
-0.06
-0.06
-0.04
-18.26
18.61
-9.46
Opening Cash & Equivalents
2.71
2.95
2.66
2.71
2.77
2.81
21.07
2.46
11.93
Closing Cash & Equivalent
8.48
2.71
2.95
2.66
2.71
2.77
2.81
21.07
2.46

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
-17.93
8.06
16.03
20.73
30.57
38.47
32.90
30.44
28.74
ROA
-1.97%
-15.02%
-10.68%
-10.50%
-7.72%
2.86%
0.58%
1.67%
0.87%
ROE
-25.42%
-67.95%
-44.15%
-40.67%
-23.51%
9.34%
2.44%
7.32%
3.61%
ROCE
-2.99%
-21.59%
-7.42%
-6.77%
-1.70%
12.60%
9.53%
11.44%
9.50%
Fixed Asset Turnover
0.58
0.57
0.59
0.83
1.10
1.65
2.03
1.98
1.47
Receivable days
132.64
205.45
301.99
335.02
330.94
243.24
186.13
180.59
235.82
Inventory Days
88.92
83.48
106.06
91.14
68.66
56.86
48.82
47.48
67.28
Payable days
221.37
261.27
174.69
155.02
168.02
144.11
132.87
159.58
181.47
Cash Conversion Cycle
0.18
27.66
233.36
271.14
231.58
155.98
102.08
68.49
121.63
Total Debt/Equity
-0.71
2.43
1.23
2.13
1.41
0.96
1.76
1.76
1.62
Interest Cover
-18.72
-7.60
-1.12
-0.77
-0.18
1.45
1.19
1.46
1.65

Annual Reports:

FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013

News Update:


  • Bafna Pharma - Quarterly Results
    12th Feb 2024, 17:08 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.